BIOCHEMICAL AND CLINICAL-STUDY OF MUSCLE ATROPHY AT THENAR AND HYPOTHENAR EMINENCES IN PATIENTS WITH CIRRHOSIS
Citation
M. Nambu et al., BIOCHEMICAL AND CLINICAL-STUDY OF MUSCLE ATROPHY AT THENAR AND HYPOTHENAR EMINENCES IN PATIENTS WITH CIRRHOSIS, Liver, 16(1), 1996, pp. 19-22
Categorie Soggetti
Gastroenterology & Hepatology
SICI code
0106-9543(1996)16:1<19:BACOMA>2.0.ZU;2-M
Abstract
The results of various biochemical examinations in 14 patients with ci
rrhosis (6 males and 8 females) with muscle atrophy at the thenar and
hypothenar eminence (muscle atrophy group; mAG) were compared with tho
se in 13 patients (8 males and 5 females) with cirrhosis without muscl
e atrophy at these sites (non-muscle atrophy group; NmAG). All patient
s were elderly men and women (mAG and NmAG, mean age, 69+/-3 years and
60+/-7, respectively). In most mAG patients, muscle atrophy was accom
panied by palmar erythema. Muscle atrophy was histologically demonstra
ted by biopsy. Furthermore, electromyography and magnetic resonance st
udy of the cervical spinal cord revealed that the atrophy was of myoge
nic rather than neurogenic origin, The Child-Pugh score, body mass ind
ex and sex hormone level in urine (total 24 h) in the two groups were
compared along with the biochemical results. There were no significant
differences between the two groups in urine estrogen and testosterone
levels. The urinary creatinine excretion was significantly reduced in
mAG, The creatine phosphokinese, lactate dehydrogenase isoenzyme and
aldolase levels in serum did not differ significantly in the two group
s, whereas the serum albumin level was significantly increased in NmAG
. Significant differences were observed only for the serum albumin lev
el, age and body mass index. Thus, we consider that palmar muscle atro
phy in patients with cirrhosis is not due to hormonal excess in serum,
but may be attributable to advanced age and diminished physical stren
gth.